Biacore Establishes New Technology Supply Division

Biacore Establishes New Technology Supply Division Lars-Åke Lejon appointed to head up new unit Uppsala, Sweden, August 11, 2000. Biacore International AB (Biacore) (SSE: BCOR; Nasdaq: BCOR) today announces the appointment of Mr Lars-Åke Lejon as Vice President and Head of Technology Supply. His role will be to lead and manage the new Technology Supply division, which will bring together the Company's extensive technical resources in research and development, manufacturing, quality assurance and product management. Mr Lejon joins Biacore from Amersham Pharmacia Biotech where, amongst other roles, he worked as Section Manager in R&D and as a project manager for various drug discovery products. He holds a Master of Science degree in Engineering Physics. "Mr Lejon brings extensive technical and project management experience to Biacore," commented Biacore's President Ulf Jönsson. "His broad experience will help provide focused expertise in developing our new product lines, such as the Company's new high performance systems for late stage drug discovery and new SPR array chip applications for high- throughput proteomics analysis." [Reuters: BCOR.N] - Ends - Notes to editors: Biacore is a global market leader in affinity-based biosensor technology with its own sales operations in the U.S., across Europe, in Japan, Australia and New Zealand. The technology is protected by a strong patent portfolio. Target groups consist primarily of medical and life science research laboratories and pharmaceutical and biotechnology companies all over the world. Biacore focuses on drug discovery as the prime area for future growth. Based in Uppsala, Sweden, the company is listed on the OM Stockholm Exchange and Nasdaq in the U.S. In 1999 the company had sales of SEK 340.4 million and an operating income of SEK 67.6 million. Further information on Biacore can be found on the web: www.biacore.com Address and phone: Biacore International AB Rapsgatan 7, SE-754 50 Uppsala, SWEDEN Phone: +46 (0)18-675700 Fax: +46 (0)18-150111 info@biacore.com ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/08/14/20000814BIT00450/bit0001.doc http://www.bit.se/bitonline/2000/08/14/20000814BIT00450/bit0002.pdf

About Us

Biacore™ systems for label-free interaction analysis generate unique data on molecular interactions, giving insights into biological functions and disease mechanisms, and facilitating efficient therapeutic development. Application areas include drug discovery, general life science research, antibody characterization, immunogenicity, biotherapeutic development and manufacture. Biacore AB is a GE Healthcare company. Further information: www.biacore.com

Subscribe